A Phase 1, Open-Label, First-in-Human, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT 303 in Adults with Advanced or Metastatic GPC3-Expressing Cancers, including Hepatocellular Carcinoma

Project: Research

Project Details

StatusActive
Effective start/end date25/09/24 → 24/09/26

Keywords

  • Clinical Trials
  • MTX-GPC3-303